Arvinas, Inc. (ARVN) DCF Valuation

ARVINAS, Inc. (ARVN) Valoración de DCF

US | Healthcare | Biotechnology | NASDAQ
Arvinas, Inc. (ARVN) DCF Valuation
  • ✓ Completamente Editable: Adáptelo A Sus Necesidades En Excel O Sheets
  • ✓ Diseño Profesional: Plantillas Confiables Y Estándares De La Industria
  • ✓ Predeterminadas Para Un Uso Rápido Y Eficiente
  • ✓ No Se Necesita Experiencia; Fáciles De Seguir

Arvinas, Inc. (ARVN) Bundle

Get Full Bundle:
$25 $15
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7

TOTAL:

¡Simplifique la valoración de Arvinas, Inc. (ARVN) con esta calculadora DCF personalizable! Con el Real Arvinas, Inc. (ARVN) Financials y las entradas de pronóstico ajustables, puede probar escenarios y descubrir el valor razonable de Arvinas, Inc. (ARVN) en minutos.


Discounted Cash Flow (DCF) - (USD MM)

Year AY1
2019		 AY2
2020		 AY3
2021		 AY4
2022		 AY5
2023		 FY1
2024		 FY2
2025		 FY3
2026		 FY4
2027		 FY5
2028
Revenue 43.0 21.8 46.7 131.4 78.5 100.2 127.8 163.2 208.2 265.7
Revenue Growth, % 0 -49.27 114.2 181.37 -40.26 27.62 27.62 27.62 27.62 27.62
EBITDA -68.0 -117.6 -183.6 -256.9 -394.8 -100.2 -127.8 -163.2 -208.2 -265.7
EBITDA, % -158.12 -539.41 -393.15 -195.51 -502.93 -100 -100 -100 -100 -100
Depreciation 2.3 4.0 6.0 8.2 6.7 10.3 13.1 16.7 21.4 27.3
Depreciation, % 5.24 18.46 12.85 6.24 8.54 10.27 10.27 10.27 10.27 10.27
EBIT -70.2 -121.6 -189.6 -265.1 -401.5 -100.2 -127.8 -163.2 -208.2 -265.7
EBIT, % -163.36 -557.87 -406 -201.75 -511.46 -100 -100 -100 -100 -100
Total Cash 280.9 688.5 1,502.6 1,205.3 1,261.0 100.2 127.8 163.2 208.2 265.7
Total Cash, percent .0 .0 .0 .0 .0 .0 .0 .0 .0 .0
Account Receivables 6.3 1.0 25.7 8.0 7.2
Account Receivables, % 14.61 4.59 55.03 6.09 9.17
Inventories .0 .0 4.5 5.5 .0 2.8 3.5 4.5 5.8 7.3
Inventories, % 0 0 9.64 4.19 0 2.76 2.76 2.76 2.76 2.76
Accounts Payable 4.6 7.1 31.3 5.7 17.8 27.5 35.1 44.8 57.1 72.9
Accounts Payable, % 10.6 32.57 67.02 4.34 22.68 27.44 27.44 27.44 27.44 27.44
Capital Expenditure -6.2 -6.4 -4.7 -6.8 -2.9 -12.6 -16.1 -20.6 -26.3 -33.5
Capital Expenditure, % -14.53 -29.57 -10.06 -5.18 -3.69 -12.61 -12.61 -12.61 -12.61 -12.61
Tax Rate, % -0.93432 -0.93432 -0.93432 -0.93432 -0.93432 -0.93432 -0.93432 -0.93432 -0.93432 -0.93432
EBITAT -62.1 -113.9 -181.9 -287.2 -405.3 -95.8 -122.2 -156.0 -199.0 -254.0
Depreciation
Changes in Account Receivables
Changes in Inventories
Changes in Accounts Payable
Capital Expenditure
UFCF -67.8 -108.5 -185.6 -294.7 -383.1 -101.9 -123.3 -157.4 -200.9 -256.3
WACC, % 13.7 13.71 13.71 13.71 13.71 13.71 13.71 13.71 13.71 13.71
PV UFCF
SUM PV UFCF -547.1
Long Term Growth Rate, % 2.00
Free cash flow (T + 1) -261
Terminal Value -2,234
Present Terminal Value -1,175
Enterprise Value -1,722
Net Debt -309
Equity Value -1,414
Diluted Shares Outstanding, MM 56
Equity Value Per Share -25.48

What You Will Get

  • Editable Excel Template: A fully customizable Excel-based DCF Calculator featuring pre-filled real ARVN financials.
  • Real-World Data: Historical data and forward-looking estimates (as indicated in the yellow cells).
  • Forecast Flexibility: Adjust forecast assumptions such as revenue growth, EBITDA %, and WACC.
  • Automatic Calculations: Instantly observe the effect of your inputs on Arvinas, Inc.'s valuation.
  • Professional Tool: Designed for investors, CFOs, consultants, and financial analysts.
  • User-Friendly Design: Organized for clarity and ease of use, complete with step-by-step instructions.

Key Features

  • Pre-Loaded Data: Arvinas, Inc.'s historical financial statements and pre-filled forecasts.
  • Fully Adjustable Inputs: Modify WACC, tax rates, revenue growth, and EBITDA margins as needed.
  • Instant Results: View Arvinas, Inc.'s intrinsic value recalculating in real time.
  • Clear Visual Outputs: Dashboard charts illustrate valuation results and essential metrics.
  • Built for Accuracy: A professional tool designed for analysts, investors, and finance experts.

How It Works

  • 1. Access the Template: Download and open the Excel file containing Arvinas, Inc.'s (ARVN) preloaded data.
  • 2. Adjust Assumptions: Modify key parameters such as growth rates, WACC, and capital expenditures.
  • 3. View Results Instantly: The DCF model automatically calculates the intrinsic value and NPV.
  • 4. Explore Scenarios: Evaluate multiple forecasts to assess various valuation outcomes.
  • 5. Present with Confidence: Deliver professional valuation insights to back your decisions.

Why Choose Arvinas, Inc. (ARVN) Calculator?

  • Save Time: Skip the hassle of building a model from the ground up – it's ready for immediate use.
  • Enhance Accuracy: Dependable financial data and formulas minimize valuation errors.
  • Fully Customizable: Adjust the model to align with your specific assumptions and forecasts.
  • Simple to Understand: Intuitive charts and outputs facilitate easy analysis of results.
  • Endorsed by Professionals: Crafted for experts who prioritize precision and functionality.

Who Should Use This Product?

  • Biotech Students: Explore drug development processes and analyze real-world data.
  • Researchers: Utilize advanced models for studies related to biopharmaceuticals.
  • Investors: Evaluate your investment strategies and assess valuation metrics for Arvinas, Inc. (ARVN).
  • Market Analysts: Enhance your analysis with a customizable financial model tailored for biotech firms.
  • Healthcare Entrepreneurs: Understand the valuation techniques applied to leading biotech companies like Arvinas, Inc. (ARVN).

What the Template Contains

  • Pre-Filled Data: Features Arvinas, Inc.'s historical financials and projections.
  • Discounted Cash Flow Model: Customizable DCF valuation model with automated calculations.
  • Weighted Average Cost of Capital (WACC): A dedicated sheet for calculating WACC based on user-defined inputs.
  • Key Financial Ratios: Evaluate Arvinas, Inc.'s profitability, efficiency, and leverage.
  • Customizable Inputs: Modify revenue growth, profit margins, and tax rates effortlessly.
  • Clear Dashboard: Visuals and tables summarizing essential valuation outcomes.

No products were found matching.